НовостиBenzingaUBS Initiates Coverage On Evommune with Neutral Rating, Announces Price Target of $8 UBS Initiates Coverage On Evommune with Neutral Rating, Announces Price Target of $8 Benzinga 2026.10.12 13:29 (GMT+0) Открыть на Benzinga Другие новости